Passa al contenuto
Merck

Vai a

BPS78317

PARPtrap Combo Assay Kit for PARP1 and PARP2

Sinonimo/i:

Assay Kits, ADPRT, poly (ADP-ribose) polymerase 2, poly(ADP-ribosyl)transferase 2

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Voi/SKUDisponibilitàPrezzo
384 reactions
Per informazioni sulla disponibilità, contatta il Servizio Clienti.
2760,00 €

Informazioni su questo articolo

UNSPSC Code:
41121811

2760,00 €


Per informazioni sulla disponibilità, contatta il Servizio Clienti.

​
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


manufacturer/tradename

BPS Bioscience

technique(s)

activity assay: suitable (Fluorescence Polarization)

UniProt accession no.

shipped in

dry ice

storage temp.

-65 to -96°C

General description

The PARPtrap Combo Assay Kit for PARP1 and PARP2 is a kit designed to measure DNA complex formations of PARP1 and PARP2 enzymes in a high throughput screening assay using fluorescence polarization (FP). The key to the PARPtrap Combo Assay Kit are the fluorescent-labeled DNA probes recognized by PARP1 and PARP2. In the absence of ribosylation, PARP1/2 binds to the DNA fluorescent probe, forming a large complex and resulting in the emission of highly polarized light. However, after autoribosylation, PARP1/2 dissociates from the oligonucleotide duplex, which then rotates freely, emitting less polarized light (Fig. 1). Addition of a PARP inhibitor results in trapping of PARP1/2 to the fluorescent-labeled DNA, and increases the FP signal in a dose dependent manner. The combo kit is particularly useful to directly and specifically compare, in a single assay, the effect and potency of a compound on PARP1 and PARP2. The PARPtrap Combo Assay Kit for PARP1 and PARP2 is a homogeneous fluorescence polarization assay. The FP signal is measured using a fluorescent microplate reader capable of measuring fluorescence polarization.

Application

Screen small molecules that enhance PARP1/2 trapping onto DNA for drug discovery and high throughput screening (HTS) applications, and IC50 determination.
PARP1, also known as poly-(ADP-ribose) polymerase 1 or NAD+ ADP-ribosyltransferase 1, is part of the PARP family, and it is the most abundant member. ADP ribosylation, which is the addition of an ADP-ribose to a protein, is a reversible post-translational modification of proteins mostly involved in the DNA Damage Response (DDR) pathway. Poly-ADP-ribosylation (termed PARylation) is the addition of linear or branched chains of ADP-ribose. PARP1 participates in DNA repair by non-homologous end joining (NHEJ), homologous recombination (HR), microhomology-mediated end-joining (MMEJ) and nucleotide excision repair. Dysfunction of DDR pathways can lead to oncogenesis. Overexpression of PARP1 has been found in breast and colon cancer, neuroblastoma, and others. This overexpression can lead to increasing MMEJ, an error-prone DNA repair mechanism, and genome instability leading to cancer. In addition to being involved in DDR, PARP1 is also linked to inflammation and type I diabetes. PARP2 participates in DNA repair (only 10% of the PARP activity is due to PARP2), but also in oxidative stress and mitochondrial fragmentation. Dysfunction of the DDR and oxidative stress pathways can lead to oncogenesis. Genetic ablation of PARP2 has indicated roles of PARP2 in adipogenesis, spermatogenesis and thymocyte survival. It is also a co-factor of nuclear receptors like ER (estrogen receptor) and PPAR (peroxisome proliferator-activated receptors). PARP2 is overexpressed in prostate cancer (PCa) and may contribute to the disease through the FOXA1 (forkhead box protein A1)/AR pathway. PARP1 and PARP2 are known to bind damaged DNA through its DNA-binding domains. Binding to DNA activates PARP1/2 and in the presence of NAD+ PARP1/2 ribosylates itself (auto-ribosylation) and dissociates from the DNA due to the accumulated negative charge of the ribosyl polymer. In the presence of some inhibitors, however, PARP remains bound to DNA, a phenomenon termed trapping. Trapped PARP-DNA complexes have been shown to be highly cytotoxic to cancer cells, making such inhibitors desirable in cancer therapy. Further understanding of the molecular pathways involving PARP1/2, and their contribution to disease, will continue to pave the way for new therapies for PARP1/2-linked diseases.
Datasheet and Protocols may be found here.


Pittogrammi

Corrosion

Parola di avvertenza

Danger

Codici di pericolo

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

Classe di stoccaggio

8A - Combustible corrosive hazardous materials

WGK

WGK 2



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti